Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Shai Izraeli, Ruth Shiloh et al.|Blood|2009Cited by 347
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALLBeat Bornhäuser, Jean‐Pierre Bourquin, Gunnar Cario et al.|Blood Advances|2020Cited by 11
DOWN'S Syndrome Acute Lymphoblastic LEUKEMIA: A HIGHLY Heterogeneous DISEASE DRIVEN by an Aberrant CRLF2/JAK2 Cooperation – A REPORT FROM the Ibfm-STUDY GROUP.Libi Hertzberg, Shai Izraeli, Elena Vendramini et al.|Blood|2009Cited by 5